Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-07-21

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application from Aurolife Pharma LLC to market a generic form of the antidepressant mirtazapine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirtazapine (generic) (Mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)